BioViva Sciences Inc

21/12/2025

A team of scientists at Cincinnati Children’s reports success in a mouse model at using a novel gene therapy to improve cardiac function during heart failure—and has launched efforts to continue the research.

https://pulse.ly/0ajg6gi7gg

20/12/2025

A study has linked kidney health to the biological markers of dementia, suggesting that more than 37 million Americans with chronic kidney disease are at risk of the condition.

Jana's dementia at 50 [shown left], Rebecca's at 48 [shown right], both without warning. New research links a vital organ's health directly to the disease, implicating millions.

19/12/2025

New findings may help researchers identify genetic mutations that contribute to rare diseases, by studying when and how single genes produce multiple versions of proteins.

MIT Whitehead Institute research helps identify genetic mutations that may contribute to rare diseases, by studying when and how single genes produce multiple versions of proteins. The work includes case studies of affected patients at Boston Children’s Hospital.

18/12/2025

Millions of people with vision loss are watching advances in vision restoration, and while an FDA-approved gene therapy now helps some patients with RPE65-related blindness, newer optogenetic treatments may soon offer hope to many more, including those with advanced retinal damage.
https://pulse.ly/ijabiq624h

17/12/2025

Born without an immune system. Gene therapy saved her life!

A common cold was enough to kill Cora Oakley.Born in Morristown, New Jersey, with virtually no immune system, Cora was diagnosed with severe combined...

16/12/2025

Until now, the only FDA-approved gene therapy for the disorder — Zolgensma — was limited to patients under 2 years old.

https://pulse.ly/pr9ckicged

15/12/2025

A large UCL study found that quitting smoking slows mental decline, even after decades of smoking. Researchers tracked nearly 9,500 smokers for 18 years and saw that memory and verbal skills deteriorated more slowly in those who quit. Over six years, this created about a three-year cognitive advantage compared with people who continued to smoke.

Those who give up smoking slow down their mental decline in old age as significantly as the brain otherwise ages in up to three years. A new study provides older smokers with a strong argument: it is never too late to stop smoking.

14/12/2025

Sox9 triggered specialized brain cells to go into clean-up overdrive, 'vacuuming' up plaques with increased efficiency.

https://pulse.ly/4sjinrpd1e

13/12/2025

A new study shows that stem cells exposed to space undergo stress, DNA damage, and signs of rapid aging, but many of these effects partially reverse once the cells return to healthy Earth conditions.

Human stem cells age faster in space, sparking new concerns about health risks on long-term missions.

12/12/2025

“In about one out of every five people that come into our clinic, what previously was thought to maybe be Alzheimer’s disease actually appears to be LATE,” Greg Jicha, MD, PhD, a neurologist and an associate director of the University of Kentucky’s Sanders-Brown Center on Aging, said in the article.

Older adults are increasingly being diagnosed with limbic-predominant age-related TDP-43 encephalopathy (LATE) dementia. This is in part due to new guidelines advising doctors how to identify the disease, according to a November investigation published in the The New York Times.

12/12/2025

Kids don't have a hard time with the idea CURE Why do you? "In Lambert High School's lab, Sean Lee and his classmates are teenage genetic engineers, manipulating the building blocks of life. "

To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to detect and treat Lyme disease. Their approach uses CRISPR gene editing.

11/12/2025

Faster approvals for gene therapy? The idea gained attention after “Baby KJ,” a newborn with a rare metabolic disorder, received a custom CRISPR treatment created and approved in just one week through an emergency single-patient process.

A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.